Bulletin
Investor Alert

UroGen Pharma Ltd.

NAS: URGN

GO
/marketstate/country/us

After Hours

 --Quotes are delayed by 20 min

Sep 25, 2020, 4:41 p.m.

/zigman2/quotes/202929873/composite

$

19.31

Change

0.00 0.00%

Volume

Volume 1,784

Quotes are delayed by 20 min

/zigman2/quotes/202929873/composite

Previous close

$ 19.30

$ 19.31

Change

+0.01 +0.05%

Day low

Day high

$19.08

$19.83

Open

52 week low

52 week high

$13.12

$35.21

Open

Insider Actions for UroGen Pharma Ltd.

– Purchase – Sale 1 – Number of Transactions
Date Name Shares Transaction Value
09/04/2020 Mark P. Schoenberg
Chief Medical Officer
348   Disposition at $20.2 per share. 7,029
09/04/2020 Mark P. Schoenberg
Chief Medical Officer
1,041   Derivative/Non-derivative trans. at $0 per share. 0
09/01/2020 Peter P. Pfreundschuh
Chief Financial Officer
509   Disposition at $22.82 per share. 11,615
09/01/2020 Peter P. Pfreundschuh
Chief Financial Officer
1,042   Derivative/Non-derivative trans. at $0 per share. 0
07/27/2020 Mark P. Schoenberg
Chief Medical Officer
70   Disposition at $23.51 per share. 1,645
07/27/2020 Peter P. Pfreundschuh
Chief Financial Officer
141   Disposition at $23.51 per share. 3,314
07/26/2020 Mark P. Schoenberg
Chief Medical Officer
209   Derivative/Non-derivative trans. at $0 per share. 0
07/26/2020 Peter P. Pfreundschuh
Chief Financial Officer
417   Derivative/Non-derivative trans. at $0 per share. 0
06/04/2020 Mark P. Schoenberg
Chief Medical Officer
349   Disposition at $27.51 per share. 9,600
06/04/2020 Mark P. Schoenberg
Chief Medical Officer
1,042   Derivative/Non-derivative trans. at $0 per share. 0
05/20/2020 Peter P. Pfreundschuh
Chief Financial Officer
358   Disposition at $25.07 per share. 8,975
05/20/2020 Peter P. Pfreundschuh
Chief Financial Officer
1,041   Derivative/Non-derivative trans. at $0 per share. 0
05/12/2020 Elizabeth Barrett
Chief Executive Officer
35,229   Derivative/Non-derivative trans. at $0 per share. 0
04/27/2020 Mark P. Schoenberg
Chief Medical Officer
70   Disposition at $24.35 per share. 1,704
04/27/2020 Stephen Mullennix
Chief Operating Officer
145   Disposition at $24.35 per share. 3,530
04/27/2020 Peter P. Pfreundschuh
Chief Financial Officer
141   Disposition at $24.35 per share. 3,433
04/26/2020 Mark P. Schoenberg
Chief Medical Officer
208   Derivative/Non-derivative trans. at $0 per share. 0
04/26/2020 Stephen Mullennix
Chief Operating Officer
417   Derivative/Non-derivative trans. at $0 per share. 0
04/26/2020 Peter P. Pfreundschuh
Chief Financial Officer
417   Derivative/Non-derivative trans. at $0 per share. 0
03/04/2020 Mark P. Schoenberg
Chief Medical Officer
345   Derivative/Non-derivative trans. at $29.5 per share. 10,177
03/04/2020 Mark P. Schoenberg
Chief Medical Officer
1,042   Derivative/Non-derivative trans. at $0 per share. 0

Transaction Summary

Total insider purchases and sales reported to the SEC

Timeframe Transactions Shares
Last 3 months
4 Purchases
4 Sales
2,709
1,068
Last 6 months
10 Purchases
9 Sales
41,063
2,131
Last 12 months
24 Purchases
18 Sales
177,110
6,426

Officers and Executives

Ms. Elizabeth Barrett
President, Chief Executive Officer & Director
Mr. Peter P. Pfreundschuh
Chief Financial Officer & Secretary
Dr. Moran Mieron
Director-Research & Pre-Clinical Affairs
Dr. Mark P. Schoenberg
Chief Medical Officer
Dr. Marina Konorty
EVP-Research & Development & Technical Operations
Mr. Jeff Bova
Chief Commercial Officer
Mr. Jason Smith
Chief Compliance Officer & General Counsel
Dr. Polly A. Murphy
Chief Business Officer
Dr. Elyse G. Seltzer
Chief Development Officer
Ms. Christine Cassiano
Corporate Affairs
Mr. Jason Patel
Vice President-Finance
Dr. Jones Woody Bryan
Senior Vice President-Business Development
Ms. Catherine Bechtold
Director-Investor Relations & Communications
Mr. James Ottinger
Executive VP-Regulatory Affairs & Quality
Dr. Arie S. Belldegrun
Chairman
Mr. Ran Nussbaum
Independent Director
Dr. Stuart Holden
Independent Director
Ms. Kathryn E. Falberg
Independent Director
Dr. Fred E. Cohen
Independent Director
Ms. Cynthia M. Butitta
Independent Director
Ms. Shawn Cline Tomasello
Independent Director
Link to MarketWatch's Slice.